Compared to anti-BCMA or anti-CD38 TCE, the binding of ISB 2001 to MM cells with low levels of both TAA was strongly increased due to avidity, and MM cell killing was superior to the combination. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.